MENU
SGMO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Sangamo Therapeutics (SGMO) Earnings Date & Reports

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

SGMO is expected to report earnings to fall 20.64% to -8 cents per share on February 25

Sangamo Therapeutics SGMO Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Missed
by $0.11
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.01
The last earnings report on November 06 showed earnings per share of -10 cents, missing the estimate of 0 cents. With 3.19M shares outstanding, the current market capitalization sits at 158.59M.
View a ticker or compare two or three
SGMO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SGMO showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of transcription factors in the regulation of genes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
501 Canal Boulevard
Phone
+1 510 970-6000
Employees
405
Web
https://www.sangamo.com